We regularly act in relation to significant M&A activity in our jurisdictions, whether as lead counsel for strictly local matters or as part of an international team for multi-jurisdictional transactions.
In addition to the negotiation of transaction documents, we assist clients with disclosure and due diligence exercises as well as obtain competition authority clearances. Our focus is a practical one; looking to allow clients the certainty to conclude a deal in the knowledge that their risk has been identified and mitigated appropriately.
Advising on acquisition finance is a key part of our services when acting on M&A transactions. We work with our corporate teams to provide solutions which may include conventional loans, leveraging the target, accessing capital markets, or typically, a combination. We act for lenders, corporates and corporate advisors.
It is important for businesses to understand what constitutes a dominant market position in order to avoid unnecessarily or unknowingly becoming involved in anti-competitive practices, especially during mergers and acquisitions. Penalties can be significant and, potentially, directors may be disqualified or worse. In addition to regularly gaining merger approvals, our commercial team also advise a number of major businesses on the practical effect of the competition regimes on their businesses.
Our team has a wealth of experience advising on all aspects of corporate acquisitions providing seamless support from agreeing heads of terms all the way through to completion.
Our experienced team will handle the due diligence process, from initial requests for information and documentation, transitioning to the review phase, making further requisitions as necessary and producing a comprehensive due diligence report setting out key issues and areas for risk mitigation.
We provide expert legal support on both local and cross border amalgamations of regulated and unregulated companies and work closely with our dispute resolution team on local schemes of arrangement.
Collas Crill has advised TEAM plc (AIM: TEAM) on its successful acquisition of JCAP Limited, trading as JCAP Treasury Services (JCAP) in a deal worth up to £2.95...
Collas Crill has advised Curaleaf on its successful acquisition of EMMAC Life Sciences Limited ('EMMAC') at an implied post money valuation of $413m. EMMAC is Europe's...
Showing 2 of 2 Results